Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$16.60 USD
+0.16 (0.97%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $16.61 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | -20.00% |
ABR | 1.10 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.58 |
Next Year | 0.60 |
EPS (TTM) | -1.73 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 37.06M | 46.66M | 166.77M | 292.10M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 39.10M | 52.70M | 184.44M | 333.70M |
Low Estimate | 33.80M | 39.70M | 144.50M | 248.00M |
Year ago Sales | 1.50M | 7.01M | 27.96M | 166.77M |
Year over Year Growth Est. | 2,370.80% | 565.56% | 496.39% | 75.15% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.08 | -0.58 | 0.60 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.13 | 0.01 | -0.29 | 0.78 |
High Estimate | -0.13 | 0.01 | -0.29 | 1.10 |
Low Estimate | -0.21 | -0.14 | -0.76 | -0.03 |
Year ago EPS | -0.70 | -0.41 | -2.00 | -0.58 |
Year over Year Growth Est. | 74.29% | 80.49% | 71.00% | 202.13% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.08 | -0.58 | 0.60 |
7 Days Ago | -0.18 | -0.08 | -0.58 | 0.60 |
30 Days Ago | -0.18 | -0.08 | -0.58 | 0.61 |
60 Days Ago | -0.18 | -0.08 | -0.58 | 0.61 |
90 Days Ago | -0.13 | -0.04 | -0.46 | 0.83 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.08 | -0.58 | 0.54 |
Zacks Consensus Estimate | -0.18 | -0.08 | -0.58 | 0.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -9.50% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.32 | -0.41 | -0.70 | NA |
Estimate | -0.25 | -0.28 | -0.35 | -0.39 | NA |
Difference | -0.05 | -0.04 | -0.06 | -0.31 | -0.12 |
Surprise | -20.00% | -14.29% | -17.14% | -79.49% | -32.73% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more